Precursor T-cell Lymphoblastic Leukemia Lymphoma

• EMA approval · 2026-04-16
  EMA Authorised: Atriance (nelarabine) — Sandoz Pharmaceuticals d.d.

  The European Medicines Agency authorized Atriance (nelarabine) for precursor T-cell lymphoblastic leukemia/lymphoma, with Sandoz Pharmaceuti…

• CLINICAL_TRIALS trial_result · 2016-12-06
  Clinical Trial Update: CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma [Phase 1, Phase 2]

  Phase 1/2 clinical trial update evaluating CAR-pNK cell immunotherapy for CD7-positive leukemias and lymphomas. The available snippet does n…